TARGET AUDIENCE
- Nurses and nurse practitioners with an interest in the management of MS
ACCREDITATION
Nurses: This educational activity is co-provided by Nurse Practitioner Alternatives (NPA), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Spire Learning.
NPA is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
NPA designates this enduring activity for a maximum of 0.5 contact hours of continuing education for nurses and nurse practitioners.
METHOD OF PARTICIPATION
There is no fee for participating and receiving CE credit for this enduring activity, which should take approximately 30 minutes to complete. If you wish to receive full credit for participating in this activity, you must view the online activity and complete the online evaluation with a 70% passing score on the posttest. We cannot award credit unless all steps are completed.
This educational activity is co-provided by Nurse Practitioner Alternatives (NPA), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Spire Learning.
This activity is supported by independent, unrestricted educational grants from Genzyme Corporation, Mallinckrodt Pharmaceuticals, and Teva Pharmaceuticals.
This activity was developed by the IOMSN as a resource for MS nurses. IOMSN has developed the content with consideration for validity, fair balance, and accuracy and is proud to endorse the activity with its logo.
OFF-LABEL STATEMENT
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this activity.
USE OF BRAND NAMES
This educational activity includes the use of brand names to minimize any confusion associated with similar agents with various formulations.
LEVELS OF EVIDENCE
Levels of evidence are provided for any clinical recommendations made during this activity.
Level A (randomized controlled trial/meta-analysis):
High-quality, randomized controlled trial (RCT) that considers all important outcomes. High-quality meta-analysis (quantitative systematic review) using comprehensive search strategies
Level B (other evidence):
A well-designed, nonrandomized clinical trial. A nonquantitative systematic review with appropriate search strategies and well-substantiated conclusions. Includes lower-quality RCTs, clinical cohort studies and case-controlled studies with nonbiased selection of study participants and consistent findings. Other evidence, such as high-quality, historical, uncontrolled studies, or well-designed epidemiologic studies with compelling findings, is also included
Level C (consensus/expert opinion):
Consensus viewpoint or expert opinion Each rating is applied to a single reference in the activity, not the entire body of evidence on the topic.
GENERAL DISCLOSURE AND COPYRIGHT STATEMENT
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the NPA, IOMSN, or Spire Learning. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should critically appraise the information presented, and draw conclusions only after careful consideration of all available scientific information.
Copyright 2015 Spire Learning. All rights reserved. No part of this activity may be reproduced or transmitted in any other form or by any means electronic or mechanical without first obtaining written permission from Spire Learning, IOMSN, or NPA.
Spire Learning, IOMSN, and NPA reserve the right to cancel or modify the activity content, faculty, and activities as necessary.